MARKET

AVTR

AVTR

Avantor
NYSE

Real-time Quotes | Nasdaq Last Sale

28.18
-0.54
-1.86%
Opening 12:43 01/15 EST
OPEN
28.65
PREV CLOSE
28.71
HIGH
28.74
LOW
27.94
VOLUME
1.86M
TURNOVER
--
52 WEEK HIGH
30.73
52 WEEK LOW
6.66
MARKET CAP
16.29B
P/E (TTM)
229.44
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Do Institutions Own Avantor, Inc. (NYSE:AVTR) Shares?
Simply Wall St. · 1d ago
Raymond James Maintains Outperform on Avantor, Raises Price Target to $34
Raymond James maintains Avantor (NYSE:AVTR) with a Outperform and raises the price target from $30 to $34.
Benzinga · 3d ago
Avantor (AVTR) Receives a Buy from Raymond James
In a report released today, Lawrence Keusch from Raymond James maintained a Buy rating on Avantor (AVTR). The company's shares closed last Monday at
SmarterAnalyst · 3d ago
Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021
, /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2020 after the market closes on , and will hold a conference call on the same day to discuss the results at .
PR Newswire - PRF · 3d ago
Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021
PR Newswire · 3d ago
*DJ Avantor Sees 4Q Free Cash Flow Greater Than $270M
Dow Jones · 4d ago
*DJ Avantor Sees 4Q Rev of $1.79B
Dow Jones · 4d ago
Avantor foresees Q4 revenue above consensus with organic growth of ~15%
Avantor (AVTR) expects Q4 revenue to be ~$1.79B resulting in estimated organic revenue growth of ~15% vs. consensus of $1.62B.FY2020 sales to grow ~6% vs. consensus of 3.04% and ~5%
Seekingalpha · 4d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVTR. Analyze the recent business situations of Avantor through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVTR stock price target is 30.30 with a high estimate of 35.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 397
Institutional Holdings: 524.22M
% Owned: 90.64%
Shares Outstanding: 578.34M
TypeInstitutionsShares
Increased
139
53.72M
New
109
25.67M
Decreased
68
68.97M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.03%
Healthcare Equipment & Supplies
+0.04%
Key Executives
Chairman/Director
Rajiv Gupta
President/Chief Executive Officer/Director
Michael Stubblefield
Chief Financial Officer/Executive Vice President
Thomas Szlosek
Chief Human Resource Officer/Executive Vice President
Eric McAllister
Executive Vice President/Chief Information Officer
Michael Wondrasch
Executive Vice President/General Counsel/Secretary
Justin Miller
Executive Vice President
James Bramwell
Executive Vice President
Gerard Brophy
Executive Vice President
Christophe Couturier
Executive Vice President
Tanya Foxe
Executive Vice President
Sven Henrichwark
Executive Vice President
Mark Murray
Executive Vice President
Devashish Ohri
Executive Vice President
Frederic Vanderhaegen
Senior Vice President/Chief Accounting Officer
Steven Eck
Director
Matthew Holt
Director
Andre Moura
Director
Jo Natauri
Independent Director
Juan Andres
Independent Director
Jonathan Peacock
Independent Director
Rakesh Sachdev
Independent Director
Michael Severino
Independent Director
Christi Shaw
Independent Director
Gregory Summe
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AVTR
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avantor Inc stock information, including NYSE:AVTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVTR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVTR stock methods without spending real money on the virtual paper trading platform.